This roundtable was initiated by All.Can UK, a multi-stakeholder initiative involving patient groups and industry experts, and has been fully funded by All.Can UK’s funding partners: Bristol Myers Squibb (lead sponsor ) and MSD (supporting sponsor). Together, the members of All.Can UK defined the focus of the event which was developed in collaboration with HSJ. Bristol Myers Squibb and MSD do not intend to encourage the use or advocate the promotion of their products through this project or any event attendees. The event did not include discussion of specific treatments or products.
Read the detailed report here.
Hosted by
The potential mental health consequences of a cancer diagnosis are multifaceted, complicated, and well established. But as the pandemic has had a huge impact on cancer care, both in diagnosing new diseases and treating and supporting people with existing illnesses, the picture has become even more complicated.
Research has suggested that the effectiveness with which the mental health needs of cancer patients are met varies significantly between organizations and regions.
To discuss how that variation might be addressed, HSJ brought together a small panel of experts for a virtual roundtable. Organized in association with All.Can UK through its funding partners Bristol Myers Squibb and MSD, the debate established both the need to rethink the way NHS cancer services are commissioned and to further strengthen knowledge and connections with provision of the third sector.
Panel:
- Sian Dennison, Head of Nursing (Cancer), University Hospitals Plymouth Trust
- Kevin Donaghy, Health and Wellness Ambassador, Melanoma UK
- Genevieve Edwards, CEO, Bowel Cancer UK
- Rakesh Koria, Macmillan, Kent and Medway GP
- Rachel Power, CEO of the Patients’ Association and President of All.Can UK
- Annabel Price, Liaison Faculty Chair, Royal College of Psychiatrists
- Naser Turabi, Chief Executive, North Central London Cancer Alliance
Preparation date: November 2021
Job Number: ONC-GB-2101018/GB-NON-05328
